{"name":"Clinuvel Europe Limited","slug":"clinuvel-europe-limited","ticker":"","exchange":"","domain":"clinuveleurope.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPdVdHdklDZW0xQ3M0d092OWR2eGp6aXF0eGQ2aURpeTZfODF4YWIxakpHNTZ4ck15emRJbVFyOVptTnUwdU9oTVVNa3NCY0VsM2tIOGZaeWF1TjF0d2RZX01tNjM2V25rWHpCTFlUU0MtazI3OF9wVmZuYThGRUlmbVZhRXQyU3ItdGRyS3VGYnA5eHZuX0tRWVlJNnJ2b2FyX3RYZ3ZYR0JQY01JN3FPTXlJWFpWeUlKSXE4TlRuNlI?oc=5","date":"2025-12-08","type":"pipeline","source":"BioSpace","summary":"CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies - BioSpace","headline":"CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNTkRZcVRuMnZuTVNFWTJsemNtUXh2alVDSnppVnRYUUNacVp5X0JjTGk4VVZBMjhwbnRBU202YVZ0VF82N1ZjWDZyVkswOWVlNnY4N2FCTFFFMWVKaS14OU4yelA4eDFjMFhISjBXRmpVT3U2b1F5MlVXemlhbXBqLTc5YXZzcTljVFFwWVY4VkFlT095cF9FLTA4c0dlWmRuMVZHam1zVmhmOFFSMDFBLUlKZWYwRjg?oc=5","date":"2025-12-02","type":"pipeline","source":"Biotech Dispatch","summary":"CLINUVEL advances second therapy toward market with planned 2026 European filing - Biotech Dispatch","headline":"CLINUVEL advances second therapy toward market with planned 2026 European filing","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-03","type":"pipeline","source":"businesswire.com","summary":"United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceuticals, Astellas Pharma, Baxter, Pfizer, Dr. Reddy's Laboratories - ResearchAndMark","headline":"United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNbHdDaUxBUGkxWXF3amJfaW12U3J1WFYwakExWmhhU0YzU05LWFBUWnhLSVdUaGlFc0liRlBaMUdpZ25oNTl4NDN4QnpMNHk1WnEzNTBpZFlLbEwyNHNWTHRzLXlXR2VMTlB1YTdaY183aVVwSF92NVpZdUxsT0NFZkNRUWMwRF84VnI3M2VpZldtcUtCQ09OSXd4ejQ?oc=5","date":"2025-09-28","type":"pipeline","source":"Yahoo Finance","summary":"CLINUVEL to advance novel pharmaceutical formulations in preclinical program - Yahoo Finance","headline":"CLINUVEL to advance novel pharmaceutical formulations in preclinical program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxNRndzbDhLZXI0RzYzSVZWTmR4cDRPeXNOWmxZcnZhbDJYTUtGSWRSSHZRNG9nZDZqNzd3TU80T2tWMjhhR3VPcHpKSElyZDBSSUZ3U3ZNY1JhVTIya2dIbXAzbUdqSU9xVFFLZTlqVjFkU3VVNEZHUzZkS1BaNlRhdmlmX1BXU3ZXYlFQMDBjN0RyRko0NjdDZ2JIdThEdVlwb3E4VEt0aGlvNC04R0xqc2R3WXQzWVlscEZDellZNVF6eTdCZ3BNRzhCNnZnRmpDcVNxeG1oQ0dJazhOYk4tbWRiNnR6RWlmTy1TLVRoN19yVWZRdGZXVjZrenpsZ3ZER2x2RlhuM3dqMFoyalJUcVZnYVJFRkhEOTNsTzQ4cHhaRFhBaWRJZXVVRXNsblkzUEdUUWF3?oc=5","date":"2025-09-23","type":"regulatory","source":"Stockhead","summary":"Health Check: Clinuvel, Telix shares surge on regulatory breakthroughs in Europe and US - Stockhead","headline":"Health Check: Clinuvel, Telix shares surge on regulatory breakthroughs in Europe and US","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-03","type":"earnings","source":"simplywall.st","summary":"Why Clinuvel Pharmaceuticals' (ASX:CUV) Earnings Are Better Than They Seem - simplywall.st","headline":"Why Clinuvel Pharmaceuticals' (ASX:CUV) Earnings Are Better Than They Seem","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNMjZaQTZrRUtBdWxxTzY0Vl94Uk5SRlVtTW16dFRtY2swVE9FNDRCbVZBbTgtQnNmckhDMVJCOEJTWkRCODNscU1VSzROVWZrdExwN2pzQWNDM0x0UGstRTFQZHZIZjl0UThiVGlJVWllekpPZnBfQzVOczVWTzJPdDQ5b1I1Ukxlbk5DNjNxWFpYWW80MVJUY2Vn?oc=5","date":"2025-08-29","type":"earnings","source":"Yahoo Finance","summary":"Clinuvel Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance","headline":"Clinuvel Pharmaceuticals Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now","sentiment":"negative"},{"url":"https://news.google.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?oc=5","date":"2025-08-29","type":"earnings","source":"simplywall.st","summary":"Clinuvel Pharmaceuticals Full Year 2025 Earnings: Misses Expectations - simplywall.st","headline":"Clinuvel Pharmaceuticals Full Year 2025 Earnings: Misses Expectations","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxONEUzcXYzTHNLQ0czMHBaMm5HeVRnNTJVbDVjQ2RHNmg2UnZkNXZEOURGWGN2RXczWFdDLTRVSnhEYUh3Tkw2QmEyeW1uZVJlN0otUFNrNjlLQnAwU2oyZjZwb00zRVFhb2JLYk0tdElIZHRzTW5qMHV4V0FITElPd0R5Uy01LWVfcGJnYk91bk5RTEpVYmw4d2Z4LUd5eTJZNUpZNnA4X1ZRUjRDQUdZVlZFV2FzWTQwU1J5OUlLTVg4NHBwVVdWRHo0bFphYTFrTmRGWjhR?oc=5","date":"2025-08-22","type":"pipeline","source":"GlobeNewswire","summary":"CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist - GlobeNewswire","headline":"CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-21","type":"pipeline","source":"simplywall.st","summary":"It's A Story Of Risk Vs Reward With Clinuvel Pharmaceuticals Limited (ASX:CUV) - simplywall.st","headline":"It's A Story Of Risk Vs Reward With Clinuvel Pharmaceuticals Limited (ASX:CUV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPM2JGYlNnU0I5czlURW5kVS1OQmxWZk0xTnAtT2txdHlNZUZTZEx3bnluRzdjZm8zci05LXY5RHJXVEo3ZmYtN3UxZnBQOC1VeVVDcjNLYzBsRXpfWnRRT3VlNDZTMHVUbkQ2ejlpYXd1WlF0eWFiM1J2S2tCbmNDYjU2WWZkbllZbUdhTWJvWjgtV2V3SWtKOThKSlZhdGNTSG5HSHhXcWJIcUlOSm4wempNZGVibTBZaU9xY1lSMk04c21YY3R5cEx1MEhKM0lncHZB?oc=5","date":"2025-05-07","type":"trial","source":"GlobeNewswire","summary":"CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105 - GlobeNewswire","headline":"CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE5XTkMzU0VRMGZjVEpQdTdhRldyc2ZXUDZrek1BVExualV3c3FVMmxGYkpEMmVOVkR5cnJmaUZFb0wyMUpveDk4V3ZBX2ZiNUxBLXI5bEt0YnFXRnNXaGNuWjlfUXdaV3oyRHRGSWs2ZjRWamRReE9JUnN3NXY0UQ?oc=5","date":"2023-07-26","type":"pipeline","source":"pharmaphorum","summary":"NICE won't budge on rejection of rare disease drug - pharmaphorum","headline":"NICE won't budge on rejection of rare disease drug","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}